A flurry of researcher posts on X arguing that AI has a double-digit probability of wiping out humanity brought the conversation right to Anthropic's doorstep. Dario Amodei, the company's co-founder and chief executive, weighed in with an essay raising alarms that people might lose command over advanced systems, that those systems could be repurposed for cyber intrusions or bioterror, and that unchecked progress could trigger severe economic upheaval unless top researchers hit the brakes.
That quickly morphed into a thorny question for a blockbuster listing: should a company try to price extinction in its IPO paperwork, or even be thought of as legally culpable for it? Many onlookers scoffed at both notions, but the risk profile for Anthropic and rival OpenAI is drawing comparisons to businesses that handle dangerous materials or sell military-grade hardware. A company representative for Anthropic said the firm had no comment.
Sam Lessin, a partner at Slow Ventures, points to the post-2008 playbook for banks as a template for AI. He argues Washington should compel AI labs to deposit $1 trillion, in cash, into an escrow account to pay for possible future cleanup, echoing how regulators forced financial institutions to carry more capital after the crisis. Even that might not cover it, he told Bloomberg News, adding, "The liabilities might be a $2 trillion or $4 trillion risk to society, even before you consider the mass-extinction they talk about, making the companies worth less than zero overall."
Despite that, Lessin says some buyers could shrug and assume someone else foots the bill if things go sideways. For now, most of the safety burden sits on the labs themselves, and investors may even like to see disciplined spending there if it builds trust.
Valuing a fast-growing private AI company is genuinely hard. Market Briefs covers that problem free every weekday.
Joe Ziolkowski, founder and CEO of Relm Insurance, says carriers are stitching together coverage for AI firms using traditional policies and bespoke add-ons, but getting insured is still a slog thanks to sparse historical data and uncertainty about how AI liability will actually show up. As AI moves from merely delivering information to making choices and working with other agents, he said, the question of who's legally on the hook when losses occur is becoming urgent.
There is almost no direct case law on autonomous AI gone wrong, which leaves investors eyeing a potential Anthropic valuation as high as $2 trillion with a stark fork in the road: accept that the company could end up bearing the full weight of extreme scenarios, or pass. "You can have an idea when you are looking at public filings how much these companies are putting into compliance or insurance or self-insuring, but it is unlikely that investors are going to discount these IPOs for exposures they can't quantify," Ziolkowski said. "It is a good time to raise capital before some of these things become objectively quantifiable."
History offers reminders that insurance can fall short. In 2010, BP's Deepwater Horizon platform blew out and went under, killing 11 and causing the largest offshore oil spill in US history; its captive insurance maxed at $700 million, while the final cost rose into the tens of billions.
Anthropic's plan to haul in as much or more than SpaceX did in its landmark debut is unfolding while AI-safety talk gets increasingly apocalyptic. SpaceX itself leaned hard into AI ambitions and rolled out its Grok model to compete with Anthropic and OpenAI, but its prospectus steered clear of existential risk, focusing instead on things like misinformation and "AI deception." The stock? It's up more than 20% over the IPO price.
InvestorPlace's chief technology analyst, Luke Lango, said President Trump's recent "morally binding" AI safety accord with tech leaders, including Amodei, eased some broader investor nerves. Adding policy context, Kevin Moss said the same, identifying himself as the Private Shares Fund's managing director and its portfolio manager: "This administration has come out and expressed concern, but this is also an administration that puts emphasis on deregulation and is in this race with China." Moss said that while AI clearly needs a regulatory structure, the safety debate likely won't derail Anthropic's listing.
Harrison Rolfes, a senior research analyst at Pitchbook covering late-stage companies, expects new safety tools to raise Anthropic's costs, but he thinks those investments could boost customer confidence and erect a defensive moat if Chinese or open-source rivals cannot meet similar standards.
If Anthropic prices up to the reported $2 trillion, you're choosing between believing the company can shoulder uncertain, potentially gigantic liabilities or deciding that's too much murk for your taste. Investors appear open to some spend on safety as a trust builder, and public filings can hint at compliance and insurance budgets. But as Ziolkowski put it, "it is unlikely that investors are going to discount these IPOs for exposures they can't quantify," which is another way of saying the market tends to look past risks it can't measure yet.
What investors settle on will anchor the whole sector's pricing. Join Market Briefs free and follow the debate.
